Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6)

Tomoyuki Hishida, Masahiro Tsuboi, Takehito Shukuya, Kazuya Takamochi, Hiroyuki Sakurai, Kiyotaka Yoh, Yasuo Ohashi, Hideo Kunitoh

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Post-operative adjuvant chemotherapy has been considered an effective strategy to reduce cancer recurrence and improve survival for resected non-small-cell lung cancer. The Japan Clinical Oncology Group has completed patient accrual for a randomized Phase III study (JCOG0707), which compares the survival benefit of UFT and S-1 for completely resected pathological Stage I (T1 >2 cm and T2 in TNM classification version 6) non-small-cell lung cancer. However, there is a growing concern that those who participated in clinical trials are highly selected patients and do not represent the 'realworld' population. This multicenter observational cohort study aims to analyze the backgrounds, pattern of care and outcomes of the patients who were excluded from the JCOG0707 study during the accrual period. The results of this cohort study will be useful for external validity of the results of clinical trial such as JCOG0707.

Original languageEnglish
Article numberhyv028
Pages (from-to)499-501
Number of pages3
JournalJapanese Journal of Clinical Oncology
Volume45
Issue number5
DOIs
Publication statusPublished - 2015 May 1
Externally publishedYes

Fingerprint

Neoplasm Staging
Non-Small Cell Lung Carcinoma
Observational Studies
Cohort Studies
Clinical Trials
Survival
Medical Oncology
Adjuvant Chemotherapy
Reproducibility of Results
Patient Care
Japan
Recurrence
Therapeutics
Population
Neoplasms
1-UFT protocol

Keywords

  • Early stage
  • Non-small-cell lung cancer
  • Observational cohort study
  • Post-operative adjuvant chemotherapy
  • Randomized Phase III study

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6). / Hishida, Tomoyuki; Tsuboi, Masahiro; Shukuya, Takehito; Takamochi, Kazuya; Sakurai, Hiroyuki; Yoh, Kiyotaka; Ohashi, Yasuo; Kunitoh, Hideo.

In: Japanese Journal of Clinical Oncology, Vol. 45, No. 5, hyv028, 01.05.2015, p. 499-501.

Research output: Contribution to journalArticle

Hishida, Tomoyuki ; Tsuboi, Masahiro ; Shukuya, Takehito ; Takamochi, Kazuya ; Sakurai, Hiroyuki ; Yoh, Kiyotaka ; Ohashi, Yasuo ; Kunitoh, Hideo. / Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6). In: Japanese Journal of Clinical Oncology. 2015 ; Vol. 45, No. 5. pp. 499-501.
@article{cc4233969e5944a7ad4a5088e70c5dd5,
title = "Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6)",
abstract = "Post-operative adjuvant chemotherapy has been considered an effective strategy to reduce cancer recurrence and improve survival for resected non-small-cell lung cancer. The Japan Clinical Oncology Group has completed patient accrual for a randomized Phase III study (JCOG0707), which compares the survival benefit of UFT and S-1 for completely resected pathological Stage I (T1 >2 cm and T2 in TNM classification version 6) non-small-cell lung cancer. However, there is a growing concern that those who participated in clinical trials are highly selected patients and do not represent the 'realworld' population. This multicenter observational cohort study aims to analyze the backgrounds, pattern of care and outcomes of the patients who were excluded from the JCOG0707 study during the accrual period. The results of this cohort study will be useful for external validity of the results of clinical trial such as JCOG0707.",
keywords = "Early stage, Non-small-cell lung cancer, Observational cohort study, Post-operative adjuvant chemotherapy, Randomized Phase III study",
author = "Tomoyuki Hishida and Masahiro Tsuboi and Takehito Shukuya and Kazuya Takamochi and Hiroyuki Sakurai and Kiyotaka Yoh and Yasuo Ohashi and Hideo Kunitoh",
year = "2015",
month = "5",
day = "1",
doi = "10.1093/jjco/hyv028",
language = "English",
volume = "45",
pages = "499--501",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6)

AU - Hishida, Tomoyuki

AU - Tsuboi, Masahiro

AU - Shukuya, Takehito

AU - Takamochi, Kazuya

AU - Sakurai, Hiroyuki

AU - Yoh, Kiyotaka

AU - Ohashi, Yasuo

AU - Kunitoh, Hideo

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Post-operative adjuvant chemotherapy has been considered an effective strategy to reduce cancer recurrence and improve survival for resected non-small-cell lung cancer. The Japan Clinical Oncology Group has completed patient accrual for a randomized Phase III study (JCOG0707), which compares the survival benefit of UFT and S-1 for completely resected pathological Stage I (T1 >2 cm and T2 in TNM classification version 6) non-small-cell lung cancer. However, there is a growing concern that those who participated in clinical trials are highly selected patients and do not represent the 'realworld' population. This multicenter observational cohort study aims to analyze the backgrounds, pattern of care and outcomes of the patients who were excluded from the JCOG0707 study during the accrual period. The results of this cohort study will be useful for external validity of the results of clinical trial such as JCOG0707.

AB - Post-operative adjuvant chemotherapy has been considered an effective strategy to reduce cancer recurrence and improve survival for resected non-small-cell lung cancer. The Japan Clinical Oncology Group has completed patient accrual for a randomized Phase III study (JCOG0707), which compares the survival benefit of UFT and S-1 for completely resected pathological Stage I (T1 >2 cm and T2 in TNM classification version 6) non-small-cell lung cancer. However, there is a growing concern that those who participated in clinical trials are highly selected patients and do not represent the 'realworld' population. This multicenter observational cohort study aims to analyze the backgrounds, pattern of care and outcomes of the patients who were excluded from the JCOG0707 study during the accrual period. The results of this cohort study will be useful for external validity of the results of clinical trial such as JCOG0707.

KW - Early stage

KW - Non-small-cell lung cancer

KW - Observational cohort study

KW - Post-operative adjuvant chemotherapy

KW - Randomized Phase III study

UR - http://www.scopus.com/inward/record.url?scp=84930005353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930005353&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyv028

DO - 10.1093/jjco/hyv028

M3 - Article

C2 - 25724215

AN - SCOPUS:84930005353

VL - 45

SP - 499

EP - 501

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 5

M1 - hyv028

ER -